Kevin Mahn, Hennion and Walsh chief investment officer, joins ‘The Exchange’ to discuss the names he’s favoring in the pharma sector.
Click here to watch the video on CNBC.
Disclosure: Hennion & Walsh Asset Management currently has allocations within its managed money program and Hennion & Walsh currently has allocations within certain SmartTrust® Unit Investment Trusts (UITs) consistent with several of the portfolios management ideas for consideration discussed during this interview.